Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

  • Harmony Outcomes committees and investigators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1519-1529
Number of pages11
JournalThe Lancet
Volume392
Issue number10157
DOIs
StatePublished - Oct 27 2018

ASJC Scopus Subject Areas

  • General Medicine

Cite this